Optimising CAR T cell therapy logistics and manufacturing strategies to ensure timely and scalable market entrance.

Faced with significant competition from earlier market entrants and a high cost of goods, our client wanted to determine the current logistics and manufacturing strategies of their competitors and identify learnings beyond the CAR T environment to inform their own activities.

Our in-depth, multi-stakeholder analysis identified key opportunities to leverage and confer a competitive advantage, ensuring timely product provision and the ability to build intimate relationships with stakeholders throughout the treatment pathway.